| Product Code: ETC12702616 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Nuclear Medicines Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Nuclear Medicines Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Nuclear Medicines Market - Industry Life Cycle |
3.4 Malaysia Nuclear Medicines Market - Porter's Five Forces |
3.5 Malaysia Nuclear Medicines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Malaysia Nuclear Medicines Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.7 Malaysia Nuclear Medicines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Malaysia Nuclear Medicines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 Malaysia Nuclear Medicines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring nuclear medicine treatments |
4.2.2 Technological advancements in nuclear medicine diagnostics and therapeutics |
4.2.3 Growing investments in healthcare infrastructure and facilities in Malaysia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approvals for nuclear medicine products |
4.3.2 Limited awareness and adoption of nuclear medicine treatments among healthcare providers and patients in Malaysia |
5 Malaysia Nuclear Medicines Market Trends |
6 Malaysia Nuclear Medicines Market, By Types |
6.1 Malaysia Nuclear Medicines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Nuclear Medicines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Malaysia Nuclear Medicines Market Revenues & Volume, By Diagnostic Radiopharmaceuticals, 2021 - 2031F |
6.1.4 Malaysia Nuclear Medicines Market Revenues & Volume, By Therapeutic Radiopharmaceuticals, 2021 - 2031F |
6.2 Malaysia Nuclear Medicines Market, By Application Area |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Nuclear Medicines Market Revenues & Volume, By Oncology Imaging, 2021 - 2031F |
6.2.3 Malaysia Nuclear Medicines Market Revenues & Volume, By Thyroid Treatment, 2021 - 2031F |
6.2.4 Malaysia Nuclear Medicines Market Revenues & Volume, By Cardiac Imaging, 2021 - 2031F |
6.2.5 Malaysia Nuclear Medicines Market Revenues & Volume, By Bone Pain Palliation, 2021 - 2031F |
6.3 Malaysia Nuclear Medicines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Nuclear Medicines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Malaysia Nuclear Medicines Market Revenues & Volume, By Endocrinology Clinics, 2021 - 2031F |
6.3.4 Malaysia Nuclear Medicines Market Revenues & Volume, By Cardiology Centers, 2021 - 2031F |
6.3.5 Malaysia Nuclear Medicines Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.4 Malaysia Nuclear Medicines Market, By Product Type |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Nuclear Medicines Market Revenues & Volume, By Technetium-99m, 2021 - 2031F |
6.4.3 Malaysia Nuclear Medicines Market Revenues & Volume, By Iodine-131, 2021 - 2031F |
6.4.4 Malaysia Nuclear Medicines Market Revenues & Volume, By Thallium-201, 2021 - 2031F |
6.4.5 Malaysia Nuclear Medicines Market Revenues & Volume, By Samarium-153, 2021 - 2031F |
7 Malaysia Nuclear Medicines Market Import-Export Trade Statistics |
7.1 Malaysia Nuclear Medicines Market Export to Major Countries |
7.2 Malaysia Nuclear Medicines Market Imports from Major Countries |
8 Malaysia Nuclear Medicines Market Key Performance Indicators |
8.1 Number of nuclear medicine procedures performed in Malaysia |
8.2 Investment in research and development for nuclear medicine technologies in the country |
8.3 Number of healthcare facilities offering nuclear medicine services in Malaysia |
9 Malaysia Nuclear Medicines Market - Opportunity Assessment |
9.1 Malaysia Nuclear Medicines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Malaysia Nuclear Medicines Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.3 Malaysia Nuclear Medicines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Malaysia Nuclear Medicines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 Malaysia Nuclear Medicines Market - Competitive Landscape |
10.1 Malaysia Nuclear Medicines Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Nuclear Medicines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here